Bio Essence Corp (BIOE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1M 2M 3M Q4 '20: 958.7K Q1 '21: 864.4K Q2 '21: 895.2K Q3 '21: 893.9K Q4 '21: 888K Q1 '22: 982.4K Q2 '22: 1M Q3 '22: 999.6K Q1 '25: 346.1K Q2 '25: 563.6K Q3 '25: 565.7K Q4 '25: 1.9M Q1 '26: 2.4M Q2 '26: 2.9M Q1 '21 Q3 '21 Q1 '22 Q3 '22 Q2 '25 Q4 '25 Q2 '26

Gross Profit TTM

0 700K 1.4M 2.1M Q4 '21: 298.3K Q1 '22: 292.1K Q2 '22: 384.9K Q3 '22: 376K Q4 '22: 328.3K Q1 '23: 424.4K Q2 '23: 376.7K Q3 '23: 310.5K Q1 '25: 237.7K Q2 '25: 377.1K Q3 '25: 391.9K Q4 '25: 1.4M Q1 '26: 1.7M Q2 '26: 2M Q1 '22 Q3 '22 Q1 '23 Q3 '23 Q2 '25 Q4 '25 Q2 '26

Operating Income TTM

-1.2M -600K 0 600K 1.2M 1.8M Q3 '21: -987.6K Q4 '21: -857.5K Q1 '22: -879.4K Q2 '22: -774K Q3 '22: -773.7K Q4 '22: -511.1K Q1 '23: -309K Q2 '23: -196.3K Q3 '23: -86.4K Q4 '23: -345.6K Q1 '24: -473.1K Q2 '24: -595K Q3 '24: -658.8K Q4 '24: -459.4K Q1 '25: -512.7K Q2 '25: -286.5K Q3 '25: -125.8K Q4 '25: 900K Q1 '26: 1.3M Q2 '26: 1.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '21: -646.5K Q4 '21: -647.6K Q1 '22: -670.3K Q2 '22: -671K Q3 '22: -687.2K Q4 '22: -809.7K Q1 '23: -755.4K Q2 '23: -875.7K Q3 '23: -991.3K Q4 '23: -971.9K Q1 '24: -659.1K Q2 '24: -590.3K Q3 '24: -1.5M Q4 '24: -1.3M Q1 '25: -1.6M Q2 '25: -1.4M Q3 '25: -160.5K Q4 '25: 896.2K Q1 '26: 1.3M Q2 '26: 1.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 350K 700K 1.1M Q4 '20: 731.4K Q1 '21: 706.5K Q2 '21: 733.2K Q3 '21: 719.3K Q4 '21: 589.7K Q1 '22: 690.3K Q2 '22: 649.7K Q3 '22: 623.6K Q1 '25: 108.5K Q2 '25: 186.4K Q3 '25: 173.8K Q4 '25: 469.2K Q1 '26: 648.7K Q2 '26: 882.7K Q1 '21 Q3 '21 Q1 '22 Q3 '22 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '21: -1.4M Q4 '21: -1.3M Q1 '22: -1.4M Q2 '22: -759.4K Q3 '22: -716.5K Q4 '22: -703.2K Q1 '23: -680.5K Q2 '23: -736.3K Q3 '23: -950.9K Q4 '23: -1M Q1 '24: -965.6K Q2 '24: -705.3K Q3 '24: -3.3K Q4 '24: 623.9K Q1 '25: 769.4K Q2 '25: 921.9K Q3 '25: 751.8K Q4 '25: 1.6M Q1 '26: 1.2M Q2 '26: 1.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-1.5M -1M -500K 0 500K 1M 1.5M Q3 '21: -1.4M Q4 '21: -1.4M Q3 '21 Q4 '21

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '21: 33M Q2 '21: 33M Q3 '21: 33M Q1 '22: 33M Q2 '22: 33M Q3 '22: 33M Q1 '23: 33M Q2 '23: 34.7M Q3 '23: 38M Q1 '24: 38M Q2 '24: 38M Q3 '24: 38M Q1 '25: 38M Q2 '25: 38M Q3 '25: 38M Q1 '26: 45M Q2 '26: 50.9M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.06 -0.04 -0.02 0.00 0.02 0.04 0.06 Q4 '20: -0.02 Q1 '21: -0.03 Q2 '21: -0.02 Q3 '21: -0.02 Q4 '21: -0.02 Q1 '22: -0.02 Q2 '22: -0.02 Q3 '22: -0.02 Q4 '22: -0.02 Q1 '23: -0.02 Q2 '23: -0.03 Q3 '23: -0.03 Q4 '23: -0.04 Q1 '24: -0.03 Q2 '24: -0.03 Q3 '24: -0.05 Q4 '24: -0.04 Q1 '25: -0.05 Q2 '25: -0.04 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.